What is the impact of OSA treated with or without CPAP on cardiovascular morbidity and mortality outcomes?

D. Testelmans (Leuven, Belgium)

Source: International Congress 2022 – PG1 Part I: Cardiovascular and neurological consequences of obstructive sleep apnoea: An update

Session: PG1 Part I: Cardiovascular and neurological consequences of obstructive sleep apnoea: An update
Session type: Postgraduate Course
Number: 4509

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Testelmans (Leuven, Belgium). What is the impact of OSA treated with or without CPAP on cardiovascular morbidity and mortality outcomes?. International Congress 2022 – PG1 Part I: Cardiovascular and neurological consequences of obstructive sleep apnoea: An update

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.